Drug Discovery R&D Collaborations
From Other Services
We work with partners to develop new disease models and new biomarkers of disease. We can also use our disease models to identify new drug targets and screen chemical compounds to identify potential new drug candidates. CENTOGENE provides companies with tools to accelerate drug discovery. From population screening studies that elucidate the prevalence of a rare disease to disease modeling, we are your partner in de-risking drug development for rare diseases.
Most popular related searches
Advancing Target Discovery to Develop New Therapies for Rare Diseases
CENTOGENE provides companies with tools and services to accelerate early drug discovery. From population screening studies that elucidate the prevalence of a rare disease, to in-vitro disease modeling, to biomarker investigation, to drug target identification, we are your partner in de-risking early drug development for rare diseases.
CENTOGENE is leveraging our multi-pronged method to diagnose, understand, and treat rare diseases to deliver compounding, exponential results and drive value creation.
In 2019, we announced a new data access and collaboration agreement with Pfizer Inc. (NYSE: PFE). The agreement grants Pfizer access to CENTOGENE’s Bio/Databank, which may be used to discover and validate novel genetic and biochemical targets and potentially develop new therapies for rare diseases.
Under the terms of the agreement, CENTOGENE and Pfizer will work together to analyze data and jointly agree to collaborate on research projects to substantiate results of data mining.
CENTOGENE’s unique Bio/Databank integrates relevant structured and unstructured patient-consented data, including clinical information, health records, and multiomic data, including genetic, transcriptomic, proteomic, and metabolomic insights. It also includes longitudinal data, such as biomarkers and patient outcomes, as well as diagnostic workflow data. Individual-level data is managed, protected, and shared in compliance with international data privacy regulations.
No reviews were found for Drug Discovery R&D Collaborations. Be the first to review!